A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Clinical trial NCT04516291 · COMPLETED

Trial details

NCT number: NCT04516291
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dyslipidemias Hyperlipidemias Hyperlipoproteinemias

Start date: 2020-09-28
Primary completion: 2021-09-29
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.